September 4, 2015
Recommended Topic Related To:

Arcapta Neohaler

"The U.S. Food and Drug Administration today approved Rapamune (sirolimus), to treat lymphangioleiomyomatosis (LAM), a rare, progressive lung disease that primarily affects women of childbearing age. This is the first drug approved to treat the di"...

Arcapta Neohaler




PATIENT INFORMATION

No information provided. Please refer to the WARNINGS AND PRECAUTIONS section.

Last reviewed on RxList: 10/15/2012
This monograph has been modified to include the generic and brand name in many instances.

Report Problems to the Food and Drug Administration

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


Women's Health

Find out what women really need.